A functionally deficient DRD2 variant [Ser311Cys] is not linked to alcoholism and substance abuse

被引:33
作者
Goldman, D [1 ]
Urbanek, M [1 ]
Guenther, D [1 ]
Robin, R [1 ]
Long, JC [1 ]
机构
[1] NIAAA, Neurogenet Lab, Rockville, MD 20852 USA
关键词
DRD2; alcoholism; Taq1A; Ser311Cys; American Indians;
D O I
10.1016/S0741-8329(97)00176-6
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Association studies with the DRD2 Taq1A marker have been variable in implicating DRD2 as a "Reward Deficiency Syndrome Gene" for alcoholism and substance abuse. Given that the Taq1A marker is not functionally significant, second-generation studies on the DRD2 receptor to identify functional variants and evaluate their effect on the phenotype are the logical step towards confirming and extending the DRD2 hypothesis. This article discusses the implications and process of progress made in these directions. The new findings are the description of structural variants in the D-2 receptor, the demonstration that one of these, Ser311Cys, largely prevents signal transduction following receptor activation and the use of Ser311Cys in a large association and sib-pair linkage anlysis in an American Indian isolate. In this particular population, the Cys311 variant is far more abundant (0.16) than in Caucasians (0.03). Genotyping of Ser311Cys, the DRD2 intron 2 STR, and the Taq1A marker in 459 subjects, including 373 sib-pairs and 15 Cys311/Cys311 homozygous individuals, revealed no association to alcoholism, substance use disorders, or schizophrenia. The implication is that a DRD2 variant that dramatically impairs receptor function was not sufficient to significantly alter alcoholism vulnerability in a relatively large and also genetically and environmentally homogeneous sample. Published by Elsevier Science Inc.
引用
收藏
页码:47 / 52
页数:6
相关论文
共 26 条
[1]   ASSOCIATION BETWEEN SEVERITY OF ALCOHOLISM AND THE A1-ALLELE OF THE DOPAMINE D2-RECEPTOR GENE TAQI-A RFLP IN JAPANESE [J].
ARINAMI, T ;
ITOKAWA, M ;
KOMIYAMA, T ;
MITSUSHIO, H ;
MORI, H ;
MIFUNE, H ;
HAMAGUCHI, H ;
TORU, M .
BIOLOGICAL PSYCHIATRY, 1993, 33 (02) :108-114
[2]   ASSOCIATION OF DOPAMINE D2 RECEPTOR MOLECULAR VARIANT WITH SCHIZOPHRENIA [J].
ARINAMI, T ;
ITOKAWA, M ;
ENGUCHI, H ;
TAGAYA, H ;
YANO, S ;
SHIMIZU, H ;
HAMAGUCHI, H ;
TORU, M .
LANCET, 1994, 343 (8899) :703-704
[3]   ALLELIC ASSOCIATION OF HUMAN DOPAMINE-D2 RECEPTOR GENE IN ALCOHOLISM [J].
BLUM, K ;
NOBLE, EP ;
SHERIDAN, PJ ;
MONTGOMERY, A ;
RITCHIE, T ;
JAGADEESWARAN, P ;
NOGAMI, H ;
BRIGGS, AH ;
COHN, JB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 263 (15) :2055-2060
[4]  
Blum K, 1996, AM SCI, V84, P132
[5]  
BOLOS AM, 1990, JAMA-J AM MED ASSOC, V264, P3156
[6]  
CASTIGLIONE CM, 1995, AM J HUM GENET, V57, P1445
[7]   Functional analysis of the human D-2 dopamine receptor missense variants [J].
Cravchik, A ;
Sibley, DR ;
Gejman, PV .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (42) :26013-26017
[8]   A family-based analysis of the association of the dopamine D2 receptor (DRD2) with alcoholism [J].
Edenberg, HJ ;
Foroud, T ;
Koller, DL ;
Goate, A ;
Rice, J ;
Van Eerdewegh, P ;
Reich, T ;
Cloninger, CR ;
Nurnberger, JI ;
Kowalczuk, M ;
Wu, B ;
Li, TK ;
Conneally, PM ;
Tischfield, JA ;
Wu, W ;
Shears, S ;
Crowe, R ;
Hesselbrock, V ;
Schuckit, M ;
Porjesz, B ;
Begleiter, H .
ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH, 1998, 22 (02) :505-512
[9]   NO STRUCTURAL MUTATION IN THE DOPAMINE-D2 RECEPTOR GENE IN ALCOHOLISM OR SCHIZOPHRENIA - ANALYSIS USING DENATURING GRADIENT GEL-ELECTROPHORESIS [J].
GEJMAN, PV ;
RAM, A ;
GELERNTER, J ;
FRIEDMAN, E ;
CAO, QH ;
PICKAR, D ;
BLUM, K ;
NOBLE, EP ;
KRANZLER, HR ;
OMALLEY, S ;
HAMER, DH ;
WHITSITT, F ;
RAO, P ;
DELISI, LE ;
VIRKKUNEN, M ;
LINNOILA, M ;
GOLDMAN, D ;
GERSHON, ES .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (03) :204-208
[10]   THE A1 ALLELE AT THE D2-DOPAMINE RECEPTOR GENE AND ALCOHOLISM - A REAPPRAISAL [J].
GELERNTER, J ;
GOLDMAN, D ;
RISCH, N .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 269 (13) :1673-1677